Skip to content

Prevention Trial Assessing Paper-Tape in Endurance Distances (PreTAPED)

Prevention Trial Assessing Paper-Tape in Endurance Distances (PreTAPED)

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01120808
Enrollment
136
Registered
2010-05-11
Start date
2010-04-30
Completion date
2011-12-31
Last updated
2018-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blister

Brief summary

Blisters are a very common complaint in both the general population and also the athlete. This study's aim is to determine whether applying paper tape (an inexpensive and common component of most foot care kits) to the foot of endurance runners prevents the frequency and severity of friction blisters.

Detailed description

Participants will be approximately 100 ultra-endurance athletes competing in Racing the Planet's 250 mile/7 day 4 Desert ultra-endurance races. A convenience sample will be used, with full consent signed before inclusion into the study, with participants being informed that study inclusion is entirely optional and will not affect medical care. A foot will berandomly selected for each participant, a coin will be flipped to determine which foot is to be taped, heads - right foot, and tails, left foot. The non-taped foot will be used as a control. No preventive treatment will be applied to the control foot. The runner's normal sock/shoe system will be used to reflect natural wilderness conditions. Runners will be excluded if any blisters, broken blisters, or hot spots are present on either foot at the time of initial taping as determined by visual foot inspection by a study administrator. The participant will also be excluded if they have a pre-existing blistering condition or known sensitivity to paper tape. Participants will have demographic data collected prior to the race, including age, gender, country of origin, number of marathons run prior, pack weight, and sock type. The study endpoint occurs when a hot spot or blister develops on either the treated or untreated foot. Runners will be instructed to treat suspected blisters or hot spots as they normally would, and to inform the study administrators the same day for visual inspection and final questionnaire to determine if they develop blisters or hot spots, whether they applied or re-applied tape themselves, removed tape, and the reasons for these actions. Participants will be allowed to have their experimental taped foot re-taped by a physician at any point in the race as deemed necessary by the runner. Before applying tape, a visual inspection will determine that feet were clean of dirt and no hot spots or blisters / broken blisters were present. Tape will be applied by trained study physicians. One inch micropore paper tape from 3M will be applied to each toe in the following manner. A piece of tape will be placed on each toe longitudinally from the base of the phalanx dorsally to the base of the phalanx on the plantar side. The tape will be smoothed against the skin. Any tape extending beyond the tip of the phalanx will be adhered together. A second piece of one inch paper tape will be applied circumferentially around each toe, with the ends of the tape located on the dorsum of the toe. In this manner, all five toes on the experimental foot will be taped. Any dog ears (tape extending beyond the phalanges) will be then trimmed with a scissors. One 2 inch piece of micropore paper tape will be applied horizontally to the posterior heel over the Achilles tendon, extending from the posterior medial malleolus to the posterior lateral malleolus. One 2 inch piece of micropore tape will be applied perpendicular to the head of the 5th metatarsal, another perpendicular to the 1st metatarsal covering medial as well as plantar aspect.

Interventions

PROCEDUREPaper tape

Paper tape assigned to each participant's randomly selected foot.

Sponsors

University of California, Davis
CollaboratorOTHER
Stanford University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* All runners who are enrolled in an RTP 4 deserts event, * All runners who are 18-75 years old, and * All runners who speak English. The study will be enrolling only those who speak English, so they can fully understand and have knowledgeable consent to the study enrollment protocols.

Exclusion criteria

* Any blisters, broken blisters, or hot spots present on either foot at the time of initial taping as determined by visual foot inspection by a enrolling study physician. * The runner has a pre-existing blistering condition.

Design outcomes

Primary

MeasureTime frame
Count of Participants With Blisters1 week

Countries

United States

Participant flow

Participants by arm

ArmCount
All Participants
Participants were registered competitors in RacingThePlanet 6 stage 7 day 155mile (250km) ultramarathon.
90
Total90

Baseline characteristics

CharacteristicAll Participants
Age, Continuous40 years
STANDARD_DEVIATION 9.4
Sex: Female, Male
Female
32 Participants
Sex: Female, Male
Male
58 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 90
serious
Total, serious adverse events
0 / 90

Outcome results

Primary

Count of Participants With Blisters

Time frame: 1 week

Population: Participants with available data were analyzed

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
All ParticipantsCount of Participants With BlistersBlisters on both feet8 Participants
All ParticipantsCount of Participants With BlistersBlister on taped foot47 Participants
All ParticipantsCount of Participants With BlistersBlister on untaped foot35 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026